Prostate cancer screening with prostate-specific antigen: Where are we going?
- PMID: 29231972
- DOI: 10.1002/cncr.31140
Prostate cancer screening with prostate-specific antigen: Where are we going?
Comment on
-
Comparative effectiveness of prostate cancer screening between the ages of 55 and 69 years followed by active surveillance.Cancer. 2018 Feb 1;124(3):507-513. doi: 10.1002/cncr.31141. Epub 2017 Dec 12. Cancer. 2018. PMID: 29231973 Free PMC article.
Similar articles
-
Prognostic Significance of Digital Rectal Examination and Prostate Specific Antigen in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Arm.J Urol. 2017 Feb;197(2):363-368. doi: 10.1016/j.juro.2016.08.092. Epub 2016 Aug 26. J Urol. 2017. PMID: 27569432 Clinical Trial.
-
Trade-Off between Treatment of Early Prostate Cancer and Incidence of Advanced Prostate Cancer in the Prostate Screening Era.J Urol. 2016 May;195(5):1397-1402. doi: 10.1016/j.juro.2015.11.056. Epub 2015 Dec 2. J Urol. 2016. PMID: 26656266
-
Decline in Prostate Cancer Screening by Primary Care Physicians: An Analysis of Trends in the Use of Digital Rectal Examination and Prostate Specific Antigen Testing.J Urol. 2016 Oct;196(4):1047-52. doi: 10.1016/j.juro.2016.03.171. Epub 2016 Apr 6. J Urol. 2016. PMID: 27060052
-
Screening for prostate cancer.Semin Oncol. 2017 Feb;44(1):47-56. doi: 10.1053/j.seminoncol.2017.02.001. Epub 2017 Feb 11. Semin Oncol. 2017. PMID: 28395763 Review.
-
Prostate Cancer Screening.Semin Oncol Nurs. 2017 May;33(2):156-164. doi: 10.1016/j.soncn.2017.02.003. Epub 2017 Mar 23. Semin Oncol Nurs. 2017. PMID: 28343840 Review.
Cited by
-
Nomograms Combining PHI and PI-RADS in Detecting Prostate Cancer: A Multicenter Prospective Study.J Clin Med. 2023 Jan 1;12(1):339. doi: 10.3390/jcm12010339. J Clin Med. 2023. PMID: 36615138 Free PMC article.
-
Clinical application of free/total PSA ratio in the diagnosis of prostate cancer in men over 50 years of age with total PSA levels of 2.0-25.0 ng ml-1 in Western China.Asian J Androl. 2022 Mar-Apr;24(2):195-200. doi: 10.4103/aja202182. Asian J Androl. 2022. PMID: 34916475 Free PMC article.
-
Concomitant High Apoptosis Inhibitor of Macrophage (AIM) and Low Prostate-Specific Antigen (PSA) Indicates Activated T Cell-Mediated Anticancer Immunity, Enhance Sensitivity to Pembrolizumab, and Elicit Good Prognosis in Prostate Cancer.Biomedicines. 2021 Sep 15;9(9):1225. doi: 10.3390/biomedicines9091225. Biomedicines. 2021. PMID: 34572412 Free PMC article.
-
ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer.J Exp Clin Cancer Res. 2021 Apr 30;40(1):149. doi: 10.1186/s13046-021-01932-8. J Exp Clin Cancer Res. 2021. PMID: 33931075 Free PMC article.
-
Identification of a novel non-invasive biological marker to overcome the shortcomings of PSA in diagnosis and risk stratification for prostate cancer: Initial prospective study of developmental endothelial locus-1 protein.PLoS One. 2021 Apr 26;16(4):e0250254. doi: 10.1371/journal.pone.0250254. eCollection 2021. PLoS One. 2021. PMID: 33901217 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
